Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
RE purchase
Credit agrmnt [a]
Asset disposition
Quarterly results
CC transcript
LIFECORE BIOMEDICAL, INC. (LNDC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/22/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
08/15/2023 SC 13D/A Cove Street Capital, LLC reports a 5.2% stake in LIFECORE BIOMEDICAL, INC
08/14/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
07/07/2023 SC 13G/A BlackRock Inc. reports a 1.8% stake in LIFECORE BIOMEDICAL, INC
06/30/2023 SC 13G Greenhaven Road Investment Management, L.P. reports a 6.3% stake in LIFECORE BIOMEDICAL, INC.
06/28/2023 SC 13D/A 22NW Fund, LP reports a 10% stake in Lifecore Biomedical, Inc.
06/12/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/09/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/06/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/01/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results"
05/22/2023 8-K Credit agreement amendment
Docs: "CREDIT AND GUARANTY AGREEMENT",
"PLEDGE AND SECURITY AGREEMENT",
"LIMITED WAIVER, CONSENT AND FIFTH AMENDMENT TO CREDIT AGREEMENT",
"EQUIPMENT SALE AND LEASEBACK AGREEMENT",
"EQUIPMENT LEASE AGREEMENT",
"AMENDED AND RESTATED SUPPLY AGREEMENT"
04/14/2023 8-K Quarterly results
04/06/2023 8-K Asset disposition
Docs: "Exhibit 99.1 Lifecore Biomedical Announces Sale of Curation"
03/27/2023 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION"
03/16/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results",
"Exhibit 99.2 Lifecore Biomedical Announces Intent to Explore Strategic Alternatives CHASKA, MN"
03/16/2023 SC 13D/A WYNNEFIELD PARTNERS SMALL CAP VALUE LP I reports a 16.6% stake in LIFECORE BIOMEDICAL, INC.
03/16/2023 10-Q Quarterly Report for the period ended November 27, 2022
03/16/2023 10-Q/A Quarterly Report for the period ended August 28, 2022 [amend]
03/16/2023 10-K/A Annual Report for the period ended May 29, 2022 [amend]
03/07/2023 SC 13D/A WYNNEFIELD PARTNERS SMALL CAP VALUE LP reports a 17.9% stake in LIFECORE BIOMEDICAL, INC.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets  Interactive Data
Docs: "SECURITIES PURCHASE AGREEMENT BY AND AMONG YUCATAN ACQUISITION HOLDINGS LLC, AS THE BUYER, YUCATAN FOODS, LLC, CAMDEN FRUIT CORP., AS THE SELLER, AND LIFECORE BIOMEDICAL, INC., AS GUARANTOR"
02/01/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/12/2023 SC 13D/A WYNNEFIELD PARTNERS SMALL CAP VALUE LP reports a 16.6% stake in LIFECORE BIOMEDICAL, INC.
01/12/2023 SC 13D Cove Street Capital, LLC reports a 7.9% stake in LIFECORE BIOMEDICAL, INC
01/11/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report January 11, 2023 CHASKA, Minn., Jan. 11, 2023"
01/10/2023 SC 13D 22NW Fund, LP reports a 10% stake in Lifecore Biomedical, Inc.
01/10/2023 SC 13D/A Legion Partners Asset Management, LLC reports a 10% stake in Lifecore Biomedical, Inc.
01/09/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
12/02/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/25/2022 8-K Quarterly results
11/16/2022 8-K Quarterly results
11/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT TO THE LANDEC CORPORATION 2019 STOCK INCENTIVE PLAN"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy